Table 3.
Female CHRs | ||||||||
---|---|---|---|---|---|---|---|---|
95% CI for Exp(P) | ||||||||
Predictor | β | SE | Wald | p | Exp(β) | Lower | Upper | |
Childhood Adjustment a | ||||||||
Social | −.29 | .23 | 1.54 | .22 | .75 | .48 | 1.18 | |
Academic | .05 | .24 | .05 | .82 | 1.06 | .67 | 1.68 | |
Baseline Global Functioning b | ||||||||
Social | −.39 | .24 | 2.69 | .10 | .68 | .43 | 1.08 | |
Role | .16 | .23 | .48 | .49 | 1.17 | .75 | 1.82 | |
Baseline Prodromal Symptomsc | ||||||||
Positive | .50 | .38 | 1.76 | .19 | 1.66 | .79 | 3.49 | |
Negative | .17 | .36 | .21 | .65 | 1.18 | .58 | 2.41 | |
Disorganized | .12 | .32 | .15 | .70 | 1.13 | .61 | 2.10 | |
Male CHRs | ||||||||
95% CI for Exp(β) | ||||||||
Predictor | β | SE | Wald | p | Exp(β) | Lower | Upper | |
Childhood Adjustment a | ||||||||
Social | .17 | .18 | .88 | .35 | 1.19 | .83 | 1.69 | |
Academic | −.03 | .22 | .01 | .91 | .98 | .64 | 1.50 | |
Baseline Global Functioning b | ||||||||
Social | −.50 | .23 | 4.83 | .03* | .60 | .39 | .95 | |
Role | .18 | .17 | 1.21 | .27 | 1.20 | .87 | 1.67 | |
Baseline Prodromal Symptoms c | ||||||||
Positive | .74 | .32 | 5.31 | .02* | 2.10 | 1.12 | 3.94 | |
Negative | .07 | .28 | .06 | .80 | 1.07 | .62 | 1.85 | |
Disorganized | .33 | .32 | 1.05 | .31 | 1.39 | .74 | 2.62 |
Note: CHR = Clinical high-risk; OR = odds ratio; CI = confidence interval.
p<.001,
p<.01,
p<.05.
Two subscales entered simultaneously.
Two subscales entered simultaneously.
Three subscales entered simultaneously.